HCI Group Inc (NYSE: HCI) has reported E.P.S. of $1.53 for its third fiscal quarter (ending September 30) versus $-5.66 for the same period a year ago. Relative to the consensus estimate of $0.31, this […]
For its third fiscal quarter (ending September 30), Zimmer Biomet Holdings Inc (NYSE: ZBH) has reported a -15% decline in E.P.S. from $0.92 a year ago to $0.78 in the current quarter. This performance was […]
On 11/7/23, Crescent Point Energy Corp (NYSE: CPG) stock suffered a major decline of -10.3%, closing at $7.17. The stock has declined -10.3% during the last week but has been exceptionally strong relative to the […]
Primoris Services Corp (NYSE: PRIM) has reported earnings for its third fiscal quarter (ending September 30) of $0.90 versus $0.81 for the same period a year ago — an increase of 11%. This performance was […]
For its third fiscal quarter (ending September 30), Sage Therapeutics Inc (NASDAQ: SAGE) has reported E.P.S. of $-3.37 compared to $-2.31 a year ago. Relative to the consensus estimate of $-2.69, this was a shortfall […]
Masimo Corp (NASDAQ: MASI) has reported earnings for its third fiscal quarter (ending September 30) of $0.20 versus $0.72 for the same period a year ago — a decline of -72%. Relative to the consensus […]
TEGNA Inc (NYSE: TGNA) has reported earnings for its third fiscal quarter (ending September 30) of $0.48 versus $0.65 for the same period a year ago — a decline of -26%. However, this result exceeded […]
Veracyte Inc (NASDAQ: VCYT) has reported a loss for its third fiscal quarter (ending September 30) of $-0.41 versus a loss $-0.12 for the same period a year ago. This result fell short of the […]
Identiv Inc (NASDAQ: INVE) has reported E.P.S. of $-0.01 for its third fiscal quarter (ending September 30) versus $0.01 for the same period a year ago — a decline of -200%. This result fell short […]
On 11/7/23, MacroGenics Inc (NASDAQ: MGNX) stock enjoyed a major increase of 17.1%, closing at $6.37. The stock has risen 23.4% during the last week but has been weak relative to the market over the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research